litlas
Log inCreate account

Steven M. Rowe

Active 2000–2025

Also published as
Steven M Rowe
149
Papers
27,233
Citations
72
h-index
144
i10-index

Citations

Citations per year for Steven M. Rowe1992: 1 citations1998: 3 citations2000: 3 citations2001: 3 citations2002: 6 citations2003: 4 citations2004: 9 citations2005: 5 citations2006: 14 citations2007: 13 citations2008: 31 citations2009: 31 citations2010: 36 citations2011: 55 citations2012: 93 citations2013: 149 citations2014: 159 citations2015: 148 citations2016: 231 citations2017: 200 citations2018: 245 citations2019: 1,020 citations2020: 1,391 citations2021: 1,632 citations2022: 1,288 citations2023: 1,136 citations2024: 1,516 citations2025: 656 citations2026: 6 citations1993–1997: no citations, so these years are not shown1999: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,378 citing papers, 31.3% of this breakdownUnited Kingdom: 673 citing papers, 8.9% of this breakdownGermany: 492 citing papers, 6.5% of this breakdownItaly: 410 citing papers, 5.4% of this breakdownCanada: 403 citing papers, 5.3% of this breakdownChina: 378 citing papers, 5% of this breakdownFrance: 348 citing papers, 4.6% of this breakdownNetherlands: 272 citing papers, 3.6% of this breakdownAustralia: 266 citing papers, 3.5% of this breakdownBelgium: 164 citing papers, 2.2% of this breakdownSwitzerland: 137 citing papers, 1.8% of this breakdownSpain: 134 citing papers, 1.8% of this breakdown
0%31.3%Other 20.1%

Institutions

Fields

  • Medicine70.7%
  • Biochemistry, Genetics and Molecular Biology19.2%
  • Immunology and Microbiology2.4%
  • Engineering1.6%
  • Neuroscience1.1%
  • Nursing0.9%
  • Other4.1%

Topics

  • Cystic Fibrosis Research Advances16.6%
  • Neonatal Respiratory Health Research9.1%
  • Tracheal and airway disorders3.3%
  • Asthma and respiratory diseases3.3%
  • Inhalation and Respiratory Drug Delivery2%
  • Chronic Obstructive Pulmonary Disease (COPD) Research1.7%
  • Other64%

Coauthors

All papers

Open in search
  1. Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

    Authors: Peter G. Middleton, Marcus Mall, Pavel Dřevı́nek, Larry C. Lands, Edward F. McKone, Deepika Polineni, Bonnie W. Ramsey, Jennifer L. Taylor‐Cousar, Elizabeth Tullis, F. Vermeulen, Gautham Marigowda, Charlotte McKee, Samuel M. Moskowitz, Nitin Nair, J. R. K. Savage, C Simard, Simon Tian, David Waltz, Fengjuan Xuan, Steven M. Rowe, Raksha Jain - New England Journal of Medicine 2019 cited by 2,116

  2. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

    Authors: Harry Heijerman, Edward F. McKone, D.G. Downey, Eva Van Braeckel, Steven M. Rowe, Elizabeth Tullis, Marcus Mall, John Welter, Bonnie W. Ramsey, Charlotte McKee, Gautham Marigowda, Samuel M. Moskowitz, David Waltz, Patrick R. Sosnay, C Simard, Neil Ahluwalia, Fengjuan Xuan, Yaohua Zhang, Jennifer L. Taylor‐Cousar, Karen McCoy, Karen McCoy, Scott H. Donaldson, Seth Walker, James F. Chmiel, Ronald C. Rubenstein, Deborah Froh, Isabel P. Neuringer, Manu Jain, Kathryn Moffett, Jennifer L. Taylor‐Cousar, Bruce Barnett, Gary A. Mueller, Patrick A. Flume, F. R. Livingston, Nighat Mehdi, Charlotte C. Tenebäck, John Welter, Raksha Jain, Dana G. Kissner, K. Patel, Francisco J. Calimano, Jimmy Johannes, Cori Daines, Thomas G. Keens, Herschel Scher, Subramanyam Chittivelu, Sudhakar Reddivalam, Ross C. Klingsberg, Larry G. Johnson, Stijn Verhulst, Patricia Macedo, D.G. Downey, Gary Connett, E.F. Nash, Nicholas Withers, Timothy Lee, Marleen Bakker, Harry Heijerman, F. Vermeulen, Eva Van Braeckel, Christiane Knoop, Elke De Wachter, Renske van der Meer, Petrus Merkus, Christof J. Majoor - The Lancet 2019 cited by 1,367

  3. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes

    Authors: Daniel T. Montoro, Adam L. Haber, Moshe Biton, Vladimir Vinarsky, Brian Lin, Susan E. Birket, Feng Yuan, Sijia Chen, Hui Min Leung, Jorge Villoria, Noga Rogel, Grace Burgin, Alexander M. Tsankov, Avinash Waghray, Michal Slyper, Julia Waldman, Lan Nguyen, Danielle Dionne, Orit Rozenblatt-Rosen, Purushothama Rao Tata, Hongmei Mou, Manjunatha Shivaraju, Hermann Bihler, Martin Mense, Guillermo J. Tearney, Steven M. Rowe, John F. Engelhardt, Aviv Regev, Jayaraj Rajagopal - Nature, Nat. 2018 cited by 1,274

  4. The future of cystic fibrosis care: a global perspective

    Authors: Scott C Bell, Marcus A Mall, Hector Gutierrez, Milan Macek, Susan Madge, Jane C Davies, Pierre-Régis Burgel, Elizabeth Tullis, Claudio Castaños, Carlo Castellani, Catherine A Byrnes, Fiona Cathcart, Sanjay H Chotirmall, Rebecca Cosgriff, Irmgard Eichler, Isabelle Fajac, Christopher H Goss, Pavel Drevinek, Philip M Farrell, Anna M Gravelle, Trudy Havermans, Nicole Mayer-Hamblett, Nataliya Kashirskaya, Eitan Kerem, Joseph L Mathew, Edward F McKone, Lutz Naehrlich, Samya Z Nasr, Gabriela R Oates, Ciaran O'Neill, Ulrike Pypops, Karen S Raraigh, Steven M Rowe, Kevin W Southern, Sheila Sivam, Anne L Stephenson, Marco Zampoli, Felix Ratjen - The Lancet Respiratory Medicine 2019 cited by 961

  5. Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial

    Authors: David P. Nichols, Alex C. Paynter, Sonya L. Heltshe, Scott H. Donaldson, Carla A. Frederick, Steven D. Freedman, Daniel Gelfond, Lucas R. Hoffman, Andrea Kelly, Michael R. Narkewicz, Jessica E. Pittman, Felix Ratjen, Margaret Rosenfeld, Scott D. Sagel, Sarah Jane Schwarzenberg, Pradeep K. Singh, George M. Solomon, Michael S. Stalvey, John P. Clancy, Shannon Kirby, Jill M. Van Dalfsen, Margaret H. Kloster, Steven M. Rowe - American Journal of Respiratory and Critical Care Medicine 2021 cited by 380

  6. Human distal airways contain a multipotent secretory cell that can regenerate alveoli

    Authors: Maria C. Basil, Fabian L. Cardenas‐Diaz, Jaymin J. Kathiriya, Michael P. Morley, Justine Carl, Alexis N. Brumwell, Jeremy Katzen, Katherine J. Slovik, Apoorva Babu, Su Zhou, Madison M. Kremp, Katherine B. McCauley, Shanru Li, Joseph D. Planer, Shah S. Hussain, Xiaoming Liu, Rebecca Windmueller, Yun Ying, Kathleen M. Stewart, M. Oyster, Jason D. Christie, Joshua M. Diamond, John F. Engelhardt, Edward Cantu, Steven M. Rowe, Darrell N. Kotton, Harold A. Chapman, Edward E. Morrisey - Nature 2022 cited by 319

  7. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation

    Authors: Bonnie W. Ramsey, Jane C. Davies, Noel G. McElvaney, Elizabeth Tullis, Scott C. Bell, Pavel Dřevínek, Matthias Griese, Edward F. McKone, Claire Wainwright, Michael W. Konstan, Richard B. Moss, Félix Ratjen, Isabelle Sermet‐Gaudelus, Steven M. Rowe, Qunming Dong, Sally Rodriguez, Karl Yen, Claudia L. Ordoñez, J.S. Elborn - New England Journal of Medicine 2011 cited by 2,174

  8. Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR

    Authors: Claire Wainwright, J.S. Elborn, Bonnie W. Ramsey, Gautham Marigowda, Xiaohong Huang, Marco Cipolli, Carla Colombo, Jane C. Davies, K. De Boeck, Patrick A. Flume, Michael W. Konstan, Susanna A. McColley, Karen McCoy, Edward F. McKone, À. Munck, Félix Ratjen, Steven M. Rowe, David Waltz, Michael Boyle - New England Journal of Medicine 2015 cited by 1,621

  9. Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist

    Authors: David P. Nichols, Sarah J. Morgan, M. Skalland, Anh T. Vo, Jill M. Van Dalfsen, Sachinkumar B. Singh, Wendy Ni, Lucas R. Hoffman, Kailee McGeer, Sonya L. Heltshe, John P. Clancy, Steven M. Rowe, Peter Jorth, Pradeep K. Singh - Journal of Clinical Investigation 2023 cited by 202

  10. VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

    Authors: D. Keating, Gautham Marigowda, Lucy Burr, Cori Daines, Marcus Mall, Edward F. McKone, Bonnie W. Ramsey, Steven M. Rowe, Laura A. Sass, Elizabeth Tullis, Charlotte McKee, Samuel M. Moskowitz, Sarah Robertson, J. R. K. Savage, C Simard, Fredrick Van Goor, David Waltz, Fengjuan Xuan, Timothy Young, Jennifer L. Taylor‐Cousar - New England Journal of Medicine 2018 cited by 727

  11. Engineered tRNAs suppress nonsense mutations in cells and in vivo

    Authors: Suki Albers, Elizabeth Cheresh Allen, Nikhil Bharti, Marcos Davyt, Disha Joshi, Carlos G. Pérez‐García, Leonardo Santos, Rajesh Mukthavaram, Miguel Angel Delgado-Toscano, Brandon Molina, Kristen Kuakini, Maher Alayyoubi, Kyoung‐Joo Jenny Park, Grishma Acharya, Jose A. Gonzalez, Amit Sagi, Susan E. Birket, Guillermo J. Tearney, Steven M. Rowe, Candela Manfredi, Jeong S. Hong, Kiyoshi Tachikawa, Priya Karmali, Daiki Matsuda, Eric J. Sorscher, Pad Chivukula, Zoya Ignatova - Nature 2023 cited by 132

  12. Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

    Authors: Steven M. Rowe, Jonathan B. Zuckerman, Daniel Dorgan, Jorge Lascano, Karen McCoy, Manu Jain, Michael S. Schechter, Sherstin T. Lommatzsch, V. Indihar, Noah Lechtzin, Kimberly McBennett, Caroline Callison, Cynthia D. Brown, Theodore G. Liou, Kelvin D. MacDonald, Samya Z. Nasr, Susan Bodie, M. Vaughn, Eric B. Meltzer, Ann Barbier - Journal of Cystic Fibrosis 2023 cited by 135

  13. Triple Therapy for Cystic Fibrosis Phe508del –Gating and –Residual Function Genotypes

    Authors: Peter J. Barry, Marcus Mall, Antonio Álvarez, Carla Colombo, Karin M. de Winter‐de Groot, Isabelle Fajac, Kimberly McBennett, Edward F. McKone, Bonnie W. Ramsey, Sivagurunathan Sutharsan, Jennifer L. Taylor‐Cousar, Elizabeth Tullis, Neil Ahluwalia, Lucy S. Jun, Samuel M. Moskowitz, Valentin Prieto-Centurion, Simon Tian, David Waltz, Fengjuan Xuan, Yao‐Hua Zhang, Steven M. Rowe, Deepika Polineni - New England Journal of Medicine 2021 cited by 275

  14. A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele

    Authors: Edith T. Zemanick, Jennifer L. Taylor‐Cousar, Jane C. Davies, Ronald L. Gibson, Marcus Mall, Edward F. McKone, Paul McNally, Bonnie W. Ramsey, Jonathan H. Rayment, Steven M. Rowe, Elizabeth Tullis, Neil Ahluwalia, Chenghao Chu, Thang Ho, Samuel M. Moskowitz, Sabrina Noël, Simon Tian, David Waltz, Tanya G. Weinstock, Fengjuan Xuan, Claire Wainwright, Susanna A. McColley - American Journal of Respiratory and Critical Care Medicine 2021 cited by 288

  15. Dual SMAD Signaling Inhibition Enables Long-Term Expansion of Diverse Epithelial Basal Cells

    Authors: Hongmei Mou, Vladimir Vinarsky, Purushothama Rao Tata, Karissa Brazauskas, Soon Ho Choi, Adrianne K. Crooke, Bing Zhang, George M. Solomon, Brett Turner, Hermann Bihler, Jan Harrington, Allen Lapey, Colleen L. Channick, Colleen Keyes, Adam Freund, Steven E. Artandi, Martin Mense, Steven M. Rowe, John F. Engelhardt, Ya‐Chieh Hsu, Jayaraj Rajagopal - Cell stem cell 2016 cited by 409

  16. Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications

    Authors: Marcus Mall, Nicole Mayer-Hamblett, Steven M. Rowe - American Journal of Respiratory and Critical Care Medicine 2019 cited by 222

  17. Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI

    Authors: Sarah Jane Schwarzenberg, Phuong T. Vu, M. Skalland, Lucas R. Hoffman, Christopher E. Pope, Daniel Gelfond, Michael R. Narkewicz, David P. Nichols, Sonya L. Heltshe, Scott H. Donaldson, Carla A. Frederick, Andrea Kelly, Jessica E. Pittman, Félix Ratjen, Margaret Rosenfeld, Scott D. Sagel, George M. Solomon, Michael S. Stalvey, John P. Clancy, Steven M. Rowe, Steven D. Freedman - Journal of Cystic Fibrosis 2022 cited by 123

  18. Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least oneF508delallele: 144-week interim results from a 192-week open-label extension study

    Authors: Cori Daines, Elizabeth Tullis, Stefano Costa, Rachel W. Linnemann, Marcus Mall, Edward F. McKone, Deepika Polineni, Bradley S. Quon, Felix C. Ringshausen, Steven M. Rowe, Hiran Selvadurai, Jennifer L. Taylor‐Cousar, Nicholas Withers, Neil Ahluwalia, Samuel M. Moskowitz, Valentin Prieto-Centurion, Yaoyuan Vincent Tan, Simon Tian, Tanya G. Weinstock, Fengjuan Xuan, Yaohua Zhang, Bonnie W. Ramsey, Matthias Griese - European Respiratory Journal 2023 cited by 88

  19. Cystic fibrosis

    Authors: Félix Ratjen, Scott C. Bell, Steven M. Rowe, Christopher H. Goss, Alexandra L. Quittner, Andrew Bush - Nature Reviews Disease Primers 2015 cited by 534

  20. A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion

    Authors: Jyoti Sharma, Ming Du, Eric C. Wong, Venkateshwar Mutyam, Yao Li, Jianguo Chen, Jamie R Wangen, K. Thrasher, Lianwu Fu, Ning Peng, Liping Tang, Kaimao Liu, Bini Mathew, Robert Bostwick, Corinne E. Augelli‐Szafran, Hermann Bihler, Feng Liang, Jérôme Mahiou, Josef Saltz, András Rab, Jeong S. Hong, Eric J. Sorscher, Eric M. Mendenhall, Candice J. Coppola, Kim M. Keeling, Rachel Green, Martin Mense, Mark J. Suto, Steven M. Rowe, David M. Bedwell - Nature Communications 2021 cited by 125

  21. Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

    Authors: Steven M. Rowe, Cori Daines, Felix C. Ringshausen, Eitan Kerem, John Wilson, Elizabeth Tullis, Nitin Nair, C Simard, Linda K. Han, Edward P. Ingenito, Charlotte McKee, Julie Lekstrom-Himes, Jane C. Davies - New England Journal of Medicine 2017 cited by 511

  22. CFTR modulator theratyping: Current status, gaps and future directions

    Authors: John P. Clancy, Calvin U. Cotton, Scott H. Donaldson, George M. Solomon, Donald R. VanDevanter, Michael Boyle, Martina Gentzsch, Jerry A. Nick, Beate Illek, J. Wallenburg, Eric J. Sorscher, Margarida D. Amaral, Jeffrey M. Beekman, Anjaparavanda P. Naren, Robert J. Bridges, Philip Thomas, Garry R. Cutting, Steven M. Rowe, Anthony G. Durmowicz, Martin Mense, K. De Boeck, William R. Skach, Christopher M. Penland, Elizabeth Joseloff, Hermann Bihler, John E. Mahoney, Drucy Borowitz, Katherine L. Tuggle - Journal of Cystic Fibrosis 2018 cited by 291

  23. Transgenic ferret models define pulmonary ionocyte diversity and function

    Authors: Feng Yuan, Grace N. Gasser, Evan Lemire, Daniel T. Montoro, Karthik A. Jagadeesh, Yan Zhang, Yifan Duan, Vitaly Ievlev, Kristen L. Wells, Pavana G. Rotti, Weam Shahin, Michael C. Winter, Bradley H. Rosen, Idil A. Evans, Qian Cai, Miao Yu, Susan A. Walsh, Michael R. Acevedo, Darpan N. Pandya, Vamsidhar Akurathi, David Dick, Thaddeus J. Wadas, Nam Soo Joo, Jeffrey J. Wine, Susan E. Birket, Courtney M. Fernandez, Hui Min Leung, Guillermo J. Tearney, A. S. Verkman, Peter M. Haggie, Kathleen Scott, D Bartels, David K. Meyerholz, Steven M. Rowe, Xiaoming Liu, Ziying Yan, Adam L. Haber, Xingshen Sun, John F. Engelhardt - Nature 2023 cited by 71

  24. Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression

    Authors: Bijoyita Roy, Westley J. Friesen, Yuki Tomizawa, John Leszyk, Jin Zhuo, Briana Johnson, Jumana Dakka, Christopher R. Trotta, Xiaojiao Xue, Venkateshwar Mutyam, Kim M. Keeling, James A. Mobley, Steven M. Rowe, David M. Bedwell, Ellen Welch, Allan Jacobson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 223